Company: WLTH
Filing Date: 2025-12-02
Form Type: S-1/A
Source: 0001628280-25-054592
Chunk: 39

Company: WEALTHFRONT CORP
Filing Date: 2025-12-02
Form: S-1/A
Chunk 39
---
 results and financial statements may not be comparable to the operating results and financial statements of other companies that have adopted the new or revised accounting standards. See the section titled “Risk Factors—Risks Related to Our Financial and Accounting Matters—We are an “emerging growth company” and the reduced reporting requirements applicable to emerging growth companies could make our common stock less attractive to investors.”

<div align='center'>29</div>

THE OFFERING

| Common stock offered by us                                         |     | 21,468,038 shares.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Common stock offered by the selling stockholders                   |     | 13,147,346 shares.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Underwriters’ option to purchase additional shares of common stock |     | The underwriters have the option for a period of 30 days from the date of this prospectus to purchase up to an additional 5,192,308 shares of common stock from us at the initial public offering price less underwriting discounts and commissions.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Common stock to be outstanding after this offering                 |     | 146,266,498 shares (or 151,458,805 shares if the underwriters exercise their option to purchase additional shares of common stock in full).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Indications of Interest                                            |     | The Cornerstone Investors have, severally and not jointly, indicated an interest in purchasing up to an aggregate of $150.0 million in shares of our common stock offered in this offering at the initial public offering price and on the same terms and conditions as the other purchasers in this offering. The shares of common stock to be purchased by the Cornerstone Investors will not be subject to a lock-up agreement with the underwriters. Because this indication of interest is not a binding agreement or commitment to purchase, the Cornerstone Investors may determine to purchase more, fewer, or no shares in this offering, or the underwriters may determine to sell more, fewer, or no shares to the Cornerstone Investors. The underwriters will receive the same underwriting discount on any shares purchased by the Cornerstone Investors as they will from the other shares sold to the public in this offering. |

<div align='center'>30</div>

| Use of proceeds |     | We estimate that the net proceeds from the sale of shares of our common stock in this offering will be approximately $255.2 million, (or approximately $318.6 million if the underwriters